Guan, X.; Verma, A.K.; Liu, Q.; Palacios, M.; Odle, A.E.; Perlman, S.; Du, L.
Glycosylated Receptor-Binding-Domain-Targeting Mucosal Vaccines Protect Against SARS-CoV-2 Omicron and MERS-CoV. Vaccines 2025, 13, 293.
https://doi.org/10.3390/vaccines13030293
AMA Style
Guan X, Verma AK, Liu Q, Palacios M, Odle AE, Perlman S, Du L.
Glycosylated Receptor-Binding-Domain-Targeting Mucosal Vaccines Protect Against SARS-CoV-2 Omicron and MERS-CoV. Vaccines. 2025; 13(3):293.
https://doi.org/10.3390/vaccines13030293
Chicago/Turabian Style
Guan, Xiaoqing, Abhishek K. Verma, Qian Liu, Melissa Palacios, Abby E. Odle, Stanley Perlman, and Lanying Du.
2025. "Glycosylated Receptor-Binding-Domain-Targeting Mucosal Vaccines Protect Against SARS-CoV-2 Omicron and MERS-CoV" Vaccines 13, no. 3: 293.
https://doi.org/10.3390/vaccines13030293
APA Style
Guan, X., Verma, A. K., Liu, Q., Palacios, M., Odle, A. E., Perlman, S., & Du, L.
(2025). Glycosylated Receptor-Binding-Domain-Targeting Mucosal Vaccines Protect Against SARS-CoV-2 Omicron and MERS-CoV. Vaccines, 13(3), 293.
https://doi.org/10.3390/vaccines13030293
